UAB Researchers Discover HIV-1 Originated in Wild ChimpanzeesMay 30, 2006BIRMINGHAM, Ala.—An international team of scientists, led by researchers at the University of Alabama at Birmingham (UAB), has discovered a crucial missing link in the search for the origin of HIV-1, the virus responsible for human AIDS. That missing link is the natural reservoir of the virus, which the team has found in wild-living chimpanzees in southern Cameroon. The findings provide important clues to how the disease migrated from non-human to human primates, and will be released Thursday (May 25) in ScienceExpress [http://www.sciencemag.org/sciencexpress/recent.dtl] and will be published in an upcoming issue of Science magazine. Although researchers have long suspected that HIV-1's origins lie in some way with chimpanzee infection through a closely related virus SIVcpz (simian immunodeficiency virus from chimpanzees), only a few captive apes had been found to harbor SIVcpz. In the study, UAB Professor of Medicine Beatrice H. Hahn, M.D., and her team conducted the first-ever molecular epidemiological survey of SIVcpz infection in wild-living chimpanzees in west-central Africa. By analyzing ape fecal samples collected by trackers from the forest floor in remote jungle regions of Cameroon, Hahn and her colleagues were able to detect SIVcpz-specific antibodies and nucleic acids (viral genetic information) in as many as 35 percent of chimpanzees in some ape communities. The UAB investigators went on to molecularly clone and sequence the complete viral genomes from four individual chimpanzees. According to UAB post-doctoral researcher Brandon Keele, Ph.D., lead author of the report, "this allowed for unprecedented genetic comparisons to be done between HIV-1 and its closest simian virus counterpart." He went on to say that "finding this cluster of naturally infected chimpanzees will allow us to explore the natural history and behavior of SIVcpz in its natural host and help us begin to unravel how and why SIVcpz made the jump to humans." Hahn, who for more than a decade has led an international effort to elucidate the origins of HIV-1, emphasized that the current study could not have succeeded without a close working partnership with Cameroonian government officials and with other collaborating scientists, including George M. Shaw, M.D., Ying Ying Li, Jun Takehisa, Mario Santiago, Frederic Bibollet-Ruche, and Yalu Chen from UAB; Fran Van Heuverswyn, Florian Liegeois, Eric Delaporte and Martine Peters from the University of Montpellier, France; Elizabeth Bailes, Louise Wain, John Brookfield and Paul Sharp from the University of Nottingham, England; and Severin Loul, Eitel Mpoudi Ngole and Yanga Bienvenue from the Project Prévention du Sida au Cameroun (PRESICA). University of Alabama at Birmingham |
|||||||||||||||||||||
| Related Hiv-1 Current Events and Hiv-1 News Articles Hoping for a fluorescent basket case Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Maternal HIV-1 treatment protects against transmission to newborns Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding. Scientists join forces to explain HIV spread in Central and East Africa Scientists studying biology and geography may seem worlds apart, but together they have answered a question that has defied explanation about the spread of the HIV-1 epidemic in Africa. Researchers induce HIV-neutralizing antibodies that recognize HIV-1 envelope protein, lipids For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids. Link uncovered between viral RNA and human immune response In its fight against an intruding virus, an enzyme in our immune system may sense certain types of viral RNA pairs, according to scientists. In vitro antibody production enables HIV infection detection in window period -- key to safer blood Researchers in Israel and Kenya have shown that the contribution of variable degrees of immune suppression, either due to existing chronic infections such as parasitemias and/or nutrition, in different populations may influence and prolong the serological-diagnostic window period of HIV. AIDS discovered in wild chimpanzees Although the AIDS virus (HIV-1) entered the human population through chimpanzees, scientists have long believed that chimpanzees don't develop AIDS. Penn-Wistar team gains insight into HIV vaccine failure A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1 vaccines. Genetic Variation Associated With Survival Advantage in African Americans With HIV From the start of the HIV epidemic, it appeared that some of the people who were infected with the virus were able to ward off the fatal effects of the disease longer than others. Study offers insights into failed HIV-1 vaccine trial Following the disbandment of the STEP trial to test the efficacy of the Merck HIV-1 vaccine candidate in 2007, the leading explanation for why the vaccine was ineffective - and may have even increased susceptibility to acquiring the virus - centered on the hypothesis that high levels of baseline Ad5-specific neutralizing antibodies may have increased HIV-1 acquisition among the study subjects who received the vaccine by increasing Ad5-specific CD4+ T-cells that were susceptible to HIV-1 infection. More Hiv-1 Current Events and Hiv-1 News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||